###begin article-title 0
Endothelial Lipase Concentrations Are Increased in Metabolic Syndrome and Associated with Coronary Atherosclerosis
###end article-title 0
###begin p 1
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 1
###begin p 2
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions:</bold>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
Author Contributions: KOB and DJR designed the study. KOB and DJR performed the experiments. KOB, MLW, and MPR analyzed the data. MLW and DJR enrolled patients. KOB, MPR, and DJR contributed to writing the paper.
###end p 2
###begin article-title 3
Endothelial Lipase: A New Risk Factor for Atherosclerosis?
###end article-title 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 281 287 <span type="species:ncbi:9606">humans</span>
Endothelial lipase (EL), a new member of the lipase family, has been shown to modulate high-density lipoprotein (HDL-C) metabolism and atherosclerosis in mouse models. We hypothesized that EL concentrations would be associated with decreased HDL-C and increased atherosclerosis in humans.
###end p 5
###begin title 6
Methods and Findings
###end title 6
###begin p 7
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 839 840 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1014 1015 1014 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1047 1048 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1084 1085 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1103 1104 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1139 1140 1139 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1149 1150 1149 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1170 1171 1170 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1199 1200 1199 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1210 1211 1210 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1232 1233 1232 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1265 1266 1265 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1284 1285 1284 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1354 1355 1354 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1393 1394 1393 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1579 1584 <span type="species:ncbi:9606">women</span>
Healthy individuals with a family history of premature coronary heart disease (n = 858) were recruited as part of the Study of the Inherited Risk of Atherosclerosis. Blood was drawn in the fasting state before and, in a subgroup (n = 510), after administration of a single dose of intravenous heparin. Plasma lipids were measured enzymatically, lipoprotein subclasses were assessed by nuclear magnetic resonance, and coronary artery calcification (CAC) was quantified by electron beam computed tomography. Plasma EL mass was measured using a newly developed enzyme-linked immunosorbent assay. Median EL mass in pre-heparin plasma was 442 (interquartile range = 324-617) ng/ml. Median post-heparin mass was approximately 3-fold higher, 1,313 (888-1,927) ng/ml. The correlation between pre-heparin EL mass and post-heparin EL mass was 0.46 (p < 0.001). EL mass concentrations in both pre- and post-heparin plasma significantly correlated with all NCEP ATPIII-defined metabolic syndrome factors: waist circumference (r = 0.28 and 0.22, respectively, p < 0.001 for each), blood pressure (r = 0.18 and 0.24, p < 0.001 for each), triglycerides (r = 0.22, p < 0.001; and 0.13, p = 0.004), HDL cholesterol (r = -0.11, p = 0.002; and -0.18, p < 0.001), and fasting glucose (r = 0.11 and 0.16, p = 0.001 for both). EL mass in both routine (odds ratio [OR] = 1.67, p = 0.01) and post-heparin (OR = 2.42, p = 0.003) plasma was associated with CAC as determined by ordinal regression after adjustment for age, gender, waist circumference, vasoactive medications, hormone replacement therapy (women), and established cardiovascular risk factors.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 276 282 <span type="species:ncbi:9606">humans</span>
We report, to our knowledge for the first time, that human plasma EL concentrations, in both post-heparin and routine pre-heparin plasma, are significantly associated with metabolic syndrome features and with subclinical atherosclerosis. EL may be a pro-atherogenic factor in humans, especially in overweight individuals and those with metabolic syndrome.
###end p 9
###begin p 10
###xml 199 205 <span type="species:ncbi:9606">humans</span>
Studies in rodents had suggested that endothelial lipase might play a role in the development of atherosclerosis. This study finds an association between EL levels and early-stage atherosclerosis in humans.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b001">1</xref>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b005">5</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b006">6</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b007">7</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b006">6</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b008">8</xref>
###xml 912 913 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b009">9</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b010">10</xref>
###xml 1087 1088 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b009">9</xref>
###xml 1089 1091 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b011">11</xref>
###xml 1210 1212 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b012">12</xref>
###xml 167 173 <span type="species:ncbi:9606">humans</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 853 858 <span type="species:ncbi:9606">human</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
###xml 1362 1368 <span type="species:ncbi:9606">humans</span>
Two members of the lipase family, lipoprotein lipase (LPL) and hepatic lipase (HL) are known to influence plasma lipoprotein metabolism and risk of atherosclerosis in humans [1-5]. Endothelial lipase (EL) is a more recently discovered member of this family of lipases [6,7]. In contrast to LPL and HL, it is expressed in endothelial cells and, in the majority of reports, has relatively more phospholipase activity than the other two enzymes. Similar to HL and LPL, it is secreted and binds to the endothelial surface. In vitro, EL effectively hydrolyzes high-density lipoprotein (HDL) phospholipids. In mice, EL has a major influence on HDL metabolism. Adenovirally mediated overexpression of human EL in mice dramatically reduced HDL cholesterol (HDL-C) concentrations [6], shown to be due to rapid catabolism of HDL [8]. Transgenic overexpression of human EL was shown to reduce HDL-C concentrations as well [9]. Conversely, antibody inhibition of EL in mice significantly increased HDL-C concentrations [10], and EL knockout mice have a significant increase in HDL-C concentrations [9,11]. Furthermore, EL knockout mice crossed onto the apolipoprotein E knockout background have decreased atherosclerosis [12]. Based on these studies in mice, it has been suggested that EL may be an important risk factor and may affect the development of atherosclerosis in humans.
###end p 12
###begin p 13
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b011">11</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b013">13</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b014">14</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b015">15</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b017">17</xref>
###xml 89 95 <span type="species:ncbi:9606">humans</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 577 583 <span type="species:ncbi:9606">humans</span>
###xml 631 636 <span type="species:ncbi:9606">human</span>
The relationship of EL to variation in lipoprotein concentrations and atherosclerosis in humans has not been reported. Several genetic association studies have suggested that rare variants and common polymorphisms in the human EL gene might be associated with variation in HDL-C concentrations [11,13,14], but they have not been conclusive and were not accompanied by direct measurement of EL concentrations. We hypothesized that concentrations of EL are inversely associated with HDL-C concentrations and directly associated with the metabolic syndrome and atherosclerosis in humans. To test this, we developed an immunoassay for human EL and used it to measure EL mass concentrations in both pre-heparin and post-heparin plasma samples in individuals enrolled in the Study of the Inherited Risk of Atherosclerosis (SIRCA). We determined the association of EL concentrations with lipoprotein concentrations, other cardiovascular risk factors and coronary artery calcification (CAC), a noninvasive measure of coronary atherosclerosis [15-17].
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study Protocol
###end title 15
###begin p 16
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b018">18</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b019">19</xref>
###xml 270 277 <span type="species:ncbi:9606">persons</span>
###xml 411 414 <span type="species:ncbi:9606">men</span>
###xml 438 443 <span type="species:ncbi:9606">women</span>
###xml 792 803 <span type="species:ncbi:9606">participant</span>
SIRCA is a cross-sectional study of asymptomatic individuals and their families designed to investigate novel biomarkers and genetic factors associated with coronary atherosclerosis. The study design and initial findings have previously been published [18,19]. Briefly, persons were eligible for SIRCA if they had a family history of premature coronary artery disease (CAD), were free of clinical CAD, and were men, 20-75 years of age or women, 30-75 years. Exclusion criteria included other major CAD risk factors: known diabetes, total cholesterol higher than 300 mg/dl, cigarette smoking of one pack or more per day, or blood pressure higher than 160/100 mm Hg. The University of Pennsylvania Institutional Review Board approved the study protocol. Informed consent was obtained from each participant. This report focuses on 858 random unrelated individuals from the SIRCA in whom plasma EL concentrations were measured.
###end p 16
###begin title 17
Evaluated Parameters
###end title 17
###begin p 18
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants were assessed at the General Clinical Research Center in the University of Pennsylvania Medical Center after a 12-h overnight fast. A questionnaire was administered; height, weight, waist circumference, and blood pressure were obtained; and 30 ml of whole blood was drawn ("pre-heparin" plasma) into EDTA-containing tubes. In a subset of individuals (n = 510), blood was drawn 10 min after intravenous administration of heparin (60 units per kilogram body weight). After the blood was centrifuged, the plasma was removed and stored at -80 degreesC until use ("post-heparin" plasma). Plasma total cholesterol, HDL cholesterol, and triglyceride concentrations were measured enzymatically on a Cobas Fara II (Roche Diagnostic Systems, Indianapolis, Indiana, United States) using Sigma reagents (Sigma, St. Louis, Missouri, United States) in a Centers for Disease Control-standardized lipid laboratory. LDL cholesterol was calculated using the Friedewald formula.
###end p 18
###begin p 19
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b020">20</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b022">22</xref>
Post-heparin plasma samples in EDTA were analyzed for lipoprotein subclasses by nuclear magnetic resonance (NMR) [20-22] (LipoSciences, Raleigh, North Carolina, United States). The NMR method uses the characteristic proton signals broadcast by lipoprotein subclasses to determine both the size and the quantity of each size of lipoprotein. A summary of the reporting format can be found at . The ten subclasses (and their size ranges) routinely used are: large very low-density lipoprotein (VLDL) (60-200 nm), intermediate VLDL (35-60 nm), small VLDL (27-35 nm), IDL (23-27 nm), large low-density lipoprotein (LDL) (21.3-23 nm), intermediate LDL (19.8-21.2 nm), small LDL (18.3-19.7 nm), large HDL (8.8-13.0 nm), intermediate HDL (8.2-8.8 nm), and small HDL (7.3-8.2 nm).
###end p 19
###begin p 20
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b023">23</xref>
Electron beam computed tomography was performed on an Imatron C-150 XP/LXP Evolution scanner (Imatron, San Francisco, California, United States) connected to a MagicView workstation for volumetric image reconstruction. Using ECG triggering with the individual in a supine position, 40 contiguous, 3 mm-thick axial slices were acquired just below the carina through the apex of the heart. Global CAC scores were determined according to the method of Agatston [23].
###end p 20
###begin title 21
###xml 47 52 <span type="species:ncbi:9606">Human</span>
Sandwich Enzyme-Linked Immunosorbent Assay for Human EL
###end title 21
###begin p 22
###xml 98 109 98 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="sd001">Protocol S1</xref>
###xml 1063 1064 1063 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1135 1136 1135 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 168 174 <span type="species:ncbi:9986">rabbit</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 246 251 <span type="species:ncbi:9606">human</span>
###xml 493 499 <span type="species:ncbi:9986">rabbit</span>
###xml 505 510 <span type="species:ncbi:9606">human</span>
###xml 549 560 <span type="species:ncbi:3704">horseradish</span>
Detailed information on the development and quality control of the sandwich ELISA can be found in Protocol S1. The wells of a 96-well microtiter plate were coated with rabbit anti-human EL antibody. Various concentrations of purified recombinant human EL in phosphate-buffered saline containing 1% BSA were added to the wells as a standard. Plasma samples were diluted 1:10 in phosphate-buffered saline and applied to the wells. Specifically bound protein was incubated with biotin-conjugated rabbit anti-human EL antibody, followed by streptavidin-horseradish peroxidase conjugate, and detection with o-phenylenediamine. The reaction was stopped with 2.5 M sulfuric acid and the plate read at 490 nm. A standard curve of 490 nm absorbance versus the known concentrations of EL was constructed. The concentration of the plasma samples was determined by comparison to the standard curve multiplied by the dilution factor. Using this ELISA, EL mass concentrations were quantified in plasma collected in the routine manner ("pre-heparin" plasma) in the full sample (n = 858) as well as in the post-heparin plasma samples described above (n = 510).
###end p 22
###begin title 23
Statistical Analysis
###end title 23
###begin p 24
###xml 803 805 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b024">24</xref>
###xml 806 808 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b025">25</xref>
###xml 1368 1370 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b026">26</xref>
###xml 1492 1494 1490 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b027">27</xref>
###xml 1510 1512 1508 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b026">26</xref>
###xml 1513 1515 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b028">28</xref>
###xml 1642 1643 1640 1641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2338 2340 2336 2338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b029">29</xref>
###xml 694 697 <span type="species:ncbi:9606">men</span>
###xml 702 707 <span type="species:ncbi:9606">women</span>
###xml 1331 1343 <span type="species:ncbi:9606">participants</span>
###xml 1776 1781 <span type="species:ncbi:9606">women</span>
Data are reported as median and interquartile range (IQR) or mean +/- standard deviation for continuous variables and as proportions for categorical variables. The distributions of both pre-heparin and post-heparin EL mass concentrations were highly skewed rightward, so analyses were performed on log-transformed data. Variables were determined to be normally distributed using the Shapiro-Wilk test. Spearman correlations of EL mass with cardiovascular risk factors and with concentrations of lipoprotein particles, measured by NMR, are presented. The association of EL mass with categorical variables was examined using Kruskal-Wallis rank test. Data were analyzed in the total group and in men and women separately, because the distributions of CAC, HDL, EL, and many risk factors vary with gender [24,25]. Differences in log-transformed EL mass by gender, and cut-points in waist circumference and other risk factors were measured by t-test. Median CAC scores were compared across quartiles of plasma EL (pre-heparin: 6-268, 268.5-422, 422.5-641, and 641.5-2,043; post-heparin: 102-888, 888.5-1,313, 1,313.5-1,927, and 1,927.5-7,505) using the Wilcoxon test for trend. Ordinal logistic regression is a method appropriate for the analysis of CAC data that has a markedly non-normal distribution and a significant proportion of participants with no detectable CAC [26]. CAC scores were divided into ordered outcome categories (0, 1-10, 11-100, 101-400, and >400) using published criteria [27] as described [26,28]. The association of EL mass with CAC was assessed in multivariable models that also included: (1) gender and age (age and age2); (2) established risk factors, gender, and age; and (3) waist circumference, medications (including hormone replacement therapy in women), established risk factors, gender, and age. Established risk factors included total (or LDL) and HDL cholesterol, triglycerides, systolic blood pressure, smoking (current versus never and ex-smokers), race, exercise (none versus any), fasting glucose, and alcohol intake (drinks per week). The results of ordinal logistic regression are presented as the odds ratio (OR) of being in a higher CAC category comparing the highest quartile of EL mass to the lowest quartile. The proportional odds assumption of ordinal regression was satisfied for all models [29]. Data analysis was performed by the authors (KOB, MR, and MW) using Stata 8.1 (Stata, College Station, Texas, United States).
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 25 37 <span type="species:ncbi:9606">Participants</span>
Characteristics of Study Participants
###end title 26
###begin p 27
###xml 64 71 64 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t001">Table 1</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b030">30</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b031">31</xref>
###xml 33 45 <span type="species:ncbi:9606">participants</span>
###xml 265 277 <span type="species:ncbi:9606">participants</span>
###xml 332 344 <span type="species:ncbi:9606">participants</span>
The characteristics of the study participants are summarized in Table 1. Compared to the 2002 CDC report on the body weight status of US adults [30], there were fewer individuals of healthy weight and more obese individuals in our cohort. The lipid profiles of our participants were similar to those reported for 20- to 59-year-old participants in the National Health and Nutrition Examination Survey III [31].
###end p 27
###begin title 28
Distribution of EL Mass Concentrations in Pre-Heparin and Post-Heparin Plasma
###end title 28
###begin p 29
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b032">32</xref>
###xml 489 490 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 687 688 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 187 193 <span type="species:ncbi:9606">humans</span>
###xml 781 784 <span type="species:ncbi:9606">men</span>
###xml 789 794 <span type="species:ncbi:9606">women</span>
###xml 858 863 <span type="species:ncbi:9606">women</span>
###xml 895 898 <span type="species:ncbi:9606">men</span>
###xml 982 985 <span type="species:ncbi:9606">men</span>
Our previous studies indicated that EL, like HL and LPL [32], is an avid heparin-binding protein (unpublished data), and we suspected that it would be released by injection of heparin in humans. Indeed, a preliminary study in 60 individuals with normal lipid profiles indicated an approximately 3- to 4-fold increase in EL mass concentrations from pre-heparin to post-heparin plasma (unpublished data). Interestingly, EL mass was abundant in pre-heparin plasma of the entire SIRCA cohort (n = 858), median = 442 (range 324-617) ng/ml. After administration of heparin, median plasma EL concentrations were approximately 3-fold higher than in pre-heparin samples, 1,313 (888-1,927) ng/ml (n = 510). There were no significant differences in pre-heparin EL mass concentrations between men and women. While median post-heparin EL concentrations were 16% lower in women, 1,165 (703-1,705) ng/ml, than men, 1,396 (944-2,031) ng/ml, this difference could be attributed to greater weight in men.
###end p 29
###begin p 30
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The correlation between pre-heparin and post-heparin EL mass was 0.46, p < 0.001. Using linear regression, pre-heparin EL mass accounted for 15% of the variation in post-heparin EL mass. While including age and gender added less than 1% each, waist circumference accounted for 5% of the variation in post-heparin EL mass.
###end p 30
###begin title 31
Association of EL Mass Concentrations with Nonlipid Cardiovascular Risk Factors
###end title 31
###begin p 32
###xml 123 124 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 219 220 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 256 257 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 363 364 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 392 393 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 468 469 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Differences in EL mass between groups in the presence and absence of other risk factors were compared by Kruskal-Wallis chi2 test. There were significant positive associations between hypertension and both pre-heparin (p = 0.004) and post-heparin EL mass (p = 0.003). There were significant negative associations between exercise and EL mass in both pre-heparin (p < 0.001) and post-heparin (p = 0.015) plasma. Smoking was associated with higher post-heparin EL mass (p = 0.005).
###end p 32
###begin p 33
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b033">33</xref>
###xml 220 227 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t002">Table 2</xref>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t002">Table 2</xref>
###xml 481 482 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 520 521 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 683 690 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t002">Table 2</xref>
###xml 855 856 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 944 945 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1039 1040 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1049 1050 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1063 1064 1055 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1073 1074 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 371 376 <span type="species:ncbi:9606">women</span>
###xml 774 777 <span type="species:ncbi:9606">men</span>
###xml 782 787 <span type="species:ncbi:9606">women</span>
Correlations of plasma EL mass with age, body mass index (BMI), waist circumference, blood pressure, fasting glucose, and the homeostasis model assessment (HOMA) index, a measure of insulin resistance [33], are shown in Table 2. There was a significant but modest positive correlation between pre-heparin EL mass and age in the entire cohort (r = 0.14, p = 0.004) and in women (r = 0.13, p = 0.013) (Table 2). There were significant positive correlations between both pre-heparin (r = 0.28, p < 0.001) and post-heparin (r = 0.22, p < 0.001) EL concentrations and both BMI and waist circumference, and these associations remained significant when each gender was examined separately (Table 2). In addition, EL concentrations were greater in obese (BMI > 30) compared to lean men and women in pre-heparin plasma, 575 +/- 364 ng/ml versus 456 +/- 328 ng/ml, p < 0.001, and in post-heparin plasma, 1,820 +/- 1,253 ng/ml versus 1,417 +/- 836 ng/ml, p < 0.001. Both pre- and post-heparin EL mass were correlated with an increased HOMA-IR score: r = 0.27, p < 0.001 and r = 0.24, p < 0.001, respectively.
###end p 33
###begin title 34
Association of EL Concentrations with Plasma Lipid and Lipoprotein Concentrations
###end title 34
###begin p 35
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t002">Table 2</xref>
###xml 322 325 <span type="species:ncbi:9606">men</span>
###xml 330 335 <span type="species:ncbi:9606">women</span>
###xml 354 359 <span type="species:ncbi:9606">women</span>
###xml 368 371 <span type="species:ncbi:9606">men</span>
Both pre-heparin and post-heparin EL mass concentrations were positively associated with aspects of an atherogenic lipoprotein profile (Table 2). In pre- and post-heparin plasma, EL mass concentrations were significantly positively correlated with fasting plasma triglyceride and apolipoprotein B (apoB) concentrations in men and women and with LDL-C in women but not men.
###end p 35
###begin p 36
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t003">Table 3</xref>
###xml 335 338 <span type="species:ncbi:9606">men</span>
###xml 343 348 <span type="species:ncbi:9606">women</span>
###xml 594 597 <span type="species:ncbi:9606">men</span>
###xml 601 606 <span type="species:ncbi:9606">women</span>
To further explore the relationship between plasma EL mass and apoB-containing lipoproteins, we examined the correlations between plasma EL mass and lipoprotein particle size as determined by NMR lipoprotein analysis (Table 3). A significant positive correlation was found between post-heparin EL mass and large VLDL concentrations in men and women, consistent with the positive association of EL with triglycerides. There was a very modest association of EL mass with concentrations of intermediate-size LDL particles in the entire group, which was not significant when assessed separately in men or women. There were no other significant associations of EL mass concentrations with apoB-containing lipoprotein subclasses.
###end p 36
###begin p 37
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t002">Table 2</xref>
###xml 420 421 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 620 627 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t003">Table 3</xref>
There was a modest, but highly statistically significant, negative association between HDL-C concentrations and both pre- and post-heparin EL concentrations (see Table 2). EL mass concentrations in the lowest and the highest HDL quartile were significantly different, with the difference more pronounced in post-heparin plasma, 1,766 +/- 1,231 ng/ml in the lowest HDL quartile versus 1,342 +/- 917 ng/ml in the highest (p = 0.001). Interestingly, the NMR analysis revealed a negative association of post-heparin EL concentrations with large HDL particles, and a positive association of EL mass with small HDL particles (Table 3). There was no correlation between either pre-heparin or post-heparin EL mass and apoA-I concentrations.
###end p 37
###begin p 38
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 448 449 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 166 178 <span type="species:ncbi:9606">participants</span>
###xml 301 306 <span type="species:ncbi:9606">women</span>
###xml 337 340 <span type="species:ncbi:9606">men</span>
###xml 422 425 <span type="species:ncbi:9606">men</span>
###xml 430 435 <span type="species:ncbi:9606">women</span>
High triglycerides and low HDL-C are two of the criteria used to diagnose metabolic syndrome. We examined the correlation between EL mass and HDL-C concentrations in participants with central obesity as defined by NCEP ATPIII metabolic syndrome waist circumference criteria (greater than 35 inches in women and greater than 40 inches in men). There were stronger negative correlations between post-heparin EL mass in both men and women, r = -0.25, p = 0.03 and r = -0.31, p = 0.03, respectively.
###end p 38
###begin p 39
###xml 223 231 223 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030022-g001">Figure 1</xref>
###xml 409 421 <span type="species:ncbi:9606">participants</span>
Since there were significant correlations between EL mass and each of the metabolic syndrome parameters, we examined differences in median post-heparin EL mass with increasing numbers of metabolic syndrome factors present (Figure 1). There was an additive effect of increasing numbers of metabolic syndrome factors, with median EL mass increasing from 328 ng/ml in individuals with no factors to 642 ng/ml in participants with all five factors present.
###end p 39
###begin title 40
Association of EL Concentrations with Coronary Artery Calcification
###end title 40
###begin p 41
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 168 176 168 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030022-g002">Figure 2</xref>
###xml 510 517 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030022-t004">Table 4</xref>
###xml 704 705 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 766 767 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 843 844 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 907 908 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 89 92 <span type="species:ncbi:9606">men</span>
###xml 129 134 <span type="species:ncbi:9606">women</span>
###xml 780 785 <span type="species:ncbi:9606">women</span>
###xml 796 799 <span type="species:ncbi:9606">men</span>
CAC scores increased across quartiles of both pre- and post-heparin EL concentrations in men (for trend, p < 0.001 for both) and women (for trend, p < 0.001 for both) (Figure 2). Using multivariable ordinal regression analyses of the entire cohort, plasma concentrations of both pre- and post-heparin EL mass were significantly associated with CAC after controlling for age, gender, and established risk factors, and after further adjustment for plasma lipids, waist circumference, and vasoactive medications (Table 4). In stratified analyses, the fourth EL quartile compared to the first was associated with higher CAC scores for both pre-heparin EL mass, OR = 1.82 (confidence interval [CI] 1.02-3.24, p = 0.043) and post-heparin EL mass, OR = 7.63 (CI 2.44-23.9, p < 0.001) in women, while in men pre-heparin EL mass, OR = 1.7 (CI 1.0-2.9, p = 0.05) but not post-heparin EL mass, OR = 1.46 (CI 0.7-3.08, p = 0.31) was significantly associated with higher CAC scores.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b034">34</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b037">37</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b034">34</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b038">38</xref>
###xml 148 153 <span type="species:ncbi:9606">human</span>
We report, to our knowledge for the first time, measurement of plasma concentrations of EL mass in routine, pre-heparin, and post-heparin plasma of human individuals. Using this newly developed sandwich ELISA, we demonstrated that EL mass concentrations in pre-heparin plasma were higher than those of LPL [34-37], and injection of heparin resulted in a 3-fold increase in plasma EL mass to concentrations similar to those reported for HL [34,38]. Importantly, within individuals, the pre-heparin and post-heparin EL concentrations are significantly correlated, suggesting that pre-heparin EL mass may be a surrogate marker for total vascular EL expression. Indeed, most of the associations between post-heparin EL mass and metabolic syndrome factors, cardiovascular risk factors, lipids, and CAC were also found for pre-heparin concentrations. This suggests that future studies of the association of EL mass concentrations with cardiovascular outcomes may be able to be performed using routine, pre-heparin plasma samples.
###end p 43
###begin p 44
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b039">39</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b040">40</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b041">41</xref>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
We previously reported that overexpression of EL in hyperlipidemic mouse models reduced concentrations of apoB-containing lipoproteins [39]. However, in this human study, we found that concentrations of EL are positively associated with plasma concentrations of LDL-C, triglycerides, and apoB, but did not correlate with the number of particles in LDL subfractions. This is in contrast to HL, which hydrolyzes remnant lipoproteins and is negatively associated with remnant particles and positively associated with concentrations of small, dense LDL particles [40]. The positive association of EL with apoB-containing lipoproteins is most likely the reflection of the concomitant increase in VLDL and triglycerides [41] and EL mass found in obese individuals and those with metabolic syndrome.
###end p 44
###begin p 45
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b006">6</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b009">9</xref>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b009">9</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b010">10</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b011">11</xref>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b008">8</xref>
###xml 1136 1138 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b042">42</xref>
###xml 1285 1287 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b043">43</xref>
###xml 48 54 <span type="species:ncbi:9606">humans</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
This is the first study to demonstrate that, in humans, EL plasma concentrations are negatively associated with HDL-C concentrations. While the negative correlations found between plasma EL mass concentrations and HDL-C concentrations are decidedly modest, they are highly statistically significant. The correlation between plasma EL mass and HDL-C may, in fact, underestimate the association of EL activity with HDL-C, given that the EL mass assay may only partially reflect the biological activity of EL. This finding is consistent with published reports in mice that overexpression of EL dramatically reduces HDL-C concentrations [6,9], and either inhibition of EL or genetic deletion causes an increase in HDL-C [9,10,11]. Furthermore, we show that EL concentrations are negatively associated with large HDL but positively associated with small HDL, consistent with the model proven in mice [8], whereby EL hydrolyzes surface phospholipids on large HDL, creating smaller, phospholipid-depleted HDL particles. This pattern of negative correlation with large HDL and positive correlation with small HDL has also been reported for HL [42]. Of significance was the lack of correlation between EL mass concentrations and apoA-I. This finding is consistent with the report by Jahangiri [43] that EL remodeling of HDL to smaller particles does not mediate apoA-I dissociation.
###end p 45
###begin p 46
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b044">44</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b045">45</xref>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b046">46</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b047">47</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b048">48</xref>
###xml 341 356 <span type="species:ncbi:10090">transgenic mice</span>
The apolipoprotein content of HDL has been shown to influence the activity of HL and EL toward HDL. Several reports by Patsch et al. [44] and Mowri et al. [45] have suggested that an increase in the apoA-II content increases HL hydrolysis of the triglyceride in the larger HDL2 particle. Recent studies by Hedrick et al. [46], using apoA-II transgenic mice, suggest that apoA-II inhibits HL activity, but the addition of apoA-I partially reverses this inhibition. Boucher et al. [47] found similar results in in vitro studies, in which the addition of apoA-II to apoA-I-containing HDL inhibited substrate hydrolysis by increasing the affinity of HL for the HDL particle. The authors reported that the addition of apoA-II to particles increased HDL size and induced a conformational change in apoA-I. In contrast, Caiazza et al. [48] used spherical HDL of identical size, containing cholesteryl ester as the sole lipid core with phosphatidylcholine and apoA-I, apoA-II, or both to determine the influence of apolipoproteins on EL activity. They found that EL hydrolysis of phospholipids in apoA-II-containing HDL was negligible, measurable in apoA-I-containing HDL, and greatest in spherical HDL containing both apoA-I and apoA-II. While the absence of triglycerides in these spherical particles makes application to native HDL difficult, it does suggest that there are differences in the subpopulations of HDL to which HL and EL bind.
###end p 46
###begin p 47
###xml 17 19 17 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b049">49</xref>
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b050">50</xref>
###xml 331 333 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b051">51</xref>
###xml 641 653 <span type="species:ncbi:9606">participants</span>
Both Jin et al. [49] and Hirata et al. [50] reported that stimulation of cultured endothelial cells with tumor necrosis factor-alpha and interleukin 1beta caused an increase in EL mRNA expression and protein secretion. Elevated plasma concentrations of tumor necrosis factor-alpha are found in individuals with metabolic syndrome [51]. The positive correlations between plasma EL mass, obesity, and the other metabolic syndrome factors provide indirect evidence of a cytokine-mediated increase in endothelial EL protein secretion in the setting of obesity and metabolic syndrome. The significant difference in EL mass between lean and obese participants also suggests that this may occur in vivo.
###end p 47
###begin p 48
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030022-b052">52</xref>
###xml 182 188 <span type="species:ncbi:9606">humans</span>
###xml 356 361 <span type="species:ncbi:9606">women</span>
###xml 370 373 <span type="species:ncbi:9606">men</span>
###xml 426 431 <span type="species:ncbi:9606">women</span>
An important finding of this study in healthy asymptomatic individuals is that EL mass concentrations are positively associated with CAC, a measure of subclinical atherosclerosis in humans, even after controlling for cardiovascular risk factors, plasma lipids, and vasoactive medications. The observation that EL tends to be a stronger predictor of CAC in women than in men could reflect the fact that HL activity is lower in women [52]. In the presence of less HL activity, EL might have a greater relative influence on HDL metabolism and atherosclerosis.
###end p 48
###begin p 49
###xml 304 309 <span type="species:ncbi:9606">human</span>
Importantly, our analysis was based on measurement of EL mass, not EL activity. LPL and HL activity are generally measured in post-heparin plasma by assaying their triglyceride lipase activity. However, EL has much less triglyceride lipase activity compared with these enzymes. Therefore, EL activity in human plasma will need to be assessed based on its phospholipase activity and will require differentiation of EL-specific activity from other sources of phospholipase activity, such as HL. The development of a validated assay will allow determination of the association between EL mass and activity and EL activity with plasma lipids and atherosclerosis.
###end p 49
###begin p 50
In summary, EL mass is present in measurable amounts in pre-heparin plasma, and increases 3-fold after administration of heparin. EL concentrations are inversely associated with total HDL-C concentrations and positively associated with obesity, triglycerides, fasting glucose, and hypertension, factors composing the metabolic syndrome. Finally, plasma EL concentrations are associated with subclinical atherosclerosis independent of all established risk factors, including plasma lipids. These data support the concept that plasma EL concentrations may modulate metabolic dyslipidemia and atherosclerosis. Prospective studies will be needed to determine if EL is, indeed, a risk factor.
###end p 50
###begin title 51
Supporting Information
###end title 51
###begin title 52
Detailed Information on the Development and Quality Control of the Sandwich ELISA
###end title 52
###begin p 53
(40 KB DOC).
###end p 53
###begin p 54
Click here for additional data file.
###end p 54
###begin title 55
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Summary
###end title 55
###begin title 56
Background
###end title 56
###begin p 57
###xml 645 651 <span type="species:ncbi:9606">people</span>
Atherosclerosis (clogging of the arteries), characterized by progressive injury to blood vessels in critical organs such as the heart and the brain, can lead to heart attacks and strokes. It is the most common cause of death and loss of quality of life in Western societies and is on the rise worldwide. In addition to high blood pressure, diabetes, obesity, and smoking, cholesterol levels are a major risk factor for atherosclerosis. Twenty years ago, we thought that high cholesterol was bad, but now we know that there several types of cholesterol, including "good cholesterol" (called HDL-C) and "bad cholesterol" (LDL-C), and that healthy people have high levels of HDL-C and low levels of LDL-C.
###end p 57
###begin title 58
Why Was This Study Done?
###end title 58
###begin p 59
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 429 435 <span type="species:ncbi:9606">humans</span>
###xml 445 450 <span type="species:ncbi:9606">Human</span>
The researchers who did this study and others had previously found a link between a molecule call endothelial lipase (EL) and atherosclerosis in mice. In mice, EL seems to decrease the levels of HDL-C, the "good cholesterol," and to make the mice more prone to atherosclerosis. Overall, mice with lower levels of EL seemed to be better off. The question was whether EL levels influenced cholesterol levels and atherosclerosis in humans as well. Human studies until now had searched for a connection between different variants of the EL gene and atherosclerosis, but had not yielded clear answers.
###end p 59
###begin title 60
What Did the Researchers Do and Find?
###end title 60
###begin p 61
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 93 105 <span type="species:ncbi:9606">participants</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 584 596 <span type="species:ncbi:9606">participants</span>
###xml 700 706 <span type="species:ncbi:9606">people</span>
In this study, the researchers directly measured levels of EL in the blood of over 800 human participants and looked for links with cholesterol levels and other atherosclerosis risk factors. They found that, just as in mice, higher blood concentrations of EL are linked with lower levels of HDL-C (the effect was clear but not very large). They also found that higher concentrations of EL were linked with other risk factors for atherosclerosis such as obesity and hypertension. Finally, they found that raised EL concentrations were linked with signs of early atherosclerosis in the participants, and this link held true even when they corrected for all other risk factors, i.e., when they compared people who had the same weight, blood pressure, and cholesterol levels.
###end p 61
###begin title 62
What Does This Mean?
###end title 62
###begin p 63
###xml 26 32 <span type="species:ncbi:9606">humans</span>
###xml 504 510 <span type="species:ncbi:9606">people</span>
The study found a link in humans between high EL concentrations in the blood, low HDL-C levels, and early stages of atherosclerosis. This suggests (but does not prove) that EL concentrations influence the risk of atherosclerosis and could be used to predict an individual's risk. Proving that EL levels predict risk can only be done in so-called "prospective studies" (studies that look forward over time, rather than go backward). Such studies would measure EL blood concentrations in a large number of people now, subdivide them into groups that differed in their EL levels but not in any other factors known to influence atherosclerosis, and then check years later whether there are differences in atherosclerosis, heart attacks, and strokes between the groups. Such studies will take time. While they are ongoing, it seems worth exploring the possibility that treatments to reduce EL levels might help prevent atherosclerosis.
###end p 63
###begin title 64
Where Can I Find More Information Online?
###end title 64
###begin p 65
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient information pages from the National Lipid Association: 
###end p 65
###begin p 66
Medline Plus pages on vascular diseases: 
###end p 66
###begin p 67
###xml 46 54 <span type="species:ncbi:9606">patients</span>
A collection of atherosclerosis resources for patients and families from the Guam Medical Library:
###end p 67
###begin p 68

###end p 68
###begin p 69
Atherosclerosis page at the University of Maryland Web site: 
###end p 69
###begin p 70
American Heart Association Web site:
###end p 70
###begin p 71

###end p 71
###begin p 72
KOB was supported by NIH training grant T32 HL-07443-25 and is currently supported by K23 HL74967-01A1. This work was also supported by R01 HL55323 (DJR) from the National Heart Lung and Blood Institute, a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (DJR), and the General Clinical Research Center of the University of Pennsylvania (M01-RR00040). DJR is also a recipient of a Doris Duke Distinguished Clinical Investigator Award. We extend our appreciation to Jennifer Dykhouse and Kimberly McMahon for their excellent technical assistance. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Effects of the hepatic lipase gene and physical activity on coronary heart disease risk
###end article-title 74
###begin article-title 75
Low hepatic lipase activity is a novel risk factor for coronary artery disease
###end article-title 75
###begin article-title 76
Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia
###end article-title 76
###begin article-title 77
The common mutations in the lipoprotein lipase gene in Italy: Effects on plasma lipids and angiographically assessed coronary atherosclerosis
###end article-title 77
###begin article-title 78
Lipoprotein lipase and atherosclerosis
###end article-title 78
###begin article-title 79
A novel endothelial-derived lipase that modulates HDL metabolism
###end article-title 79
###begin article-title 80
Cloning of a unique lipase from endothelial cells extends the lipase gene family
###end article-title 80
###begin article-title 81
Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase
###end article-title 81
###begin article-title 82
Endothelial lipase is a major determinant of HDL level
###end article-title 82
###begin article-title 83
Inhibition of endothelial lipase causes increased HDL cholesterol concentrations in vivo
###end article-title 83
###begin article-title 84
Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism
###end article-title 84
###begin article-title 85
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice
###end article-title 85
###begin article-title 86
###xml 60 67 <span type="species:ncbi:9606">persons</span>
Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol
###end article-title 86
###begin article-title 87
###xml 131 139 <span type="species:ncbi:9606">children</span>
Relationship between serum HDL-C concentrations and common genetic variants of the endothelial lipase gene in Japanese school-aged children
###end article-title 87
###begin article-title 88
Electron beam computed tomography and coronary artery disease: Scanning for coronary artery calcification
###end article-title 88
###begin article-title 89
Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography
###end article-title 89
###begin article-title 90
Electron-beam computed tomography in the diagnosis of coronary artery disease: A meta-analysis
###end article-title 90
###begin article-title 91
###xml 71 78 <span type="species:ncbi:9606">persons</span>
Association of traditional risk factors with coronary calcification in persons with a family history of premature coronary heart disease: The study of the inherited risk of coronary atherosclerosis
###end article-title 91
###begin article-title 92
C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA)
###end article-title 92
###begin article-title 93
Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy
###end article-title 93
###begin article-title 94
Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study
###end article-title 94
###begin article-title 95
Hormone therapy, lipoprotein subclasses and coronary calcification
###end article-title 95
###begin article-title 96
Quantification of coronary artery calcium using ultrafast computed tomography
###end article-title 96
###begin article-title 97
###xml 42 47 <span type="species:ncbi:9606">women</span>
Epidemiology of coronary heart disease in women
###end article-title 97
###begin article-title 98
Gender differences on the risk evaluation of acute coronary syndromes: The CARDIO2000 study
###end article-title 98
###begin article-title 99
Coronary artery calcification and cardiovascular risk factors: Impact of the analytic approach
###end article-title 99
###begin article-title 100
###xml 110 117 <span type="species:ncbi:9606">persons</span>
Electron beam computed tomographic coronary calcium scanning: A review and guidelines for use in asymptomatic persons
###end article-title 100
###begin article-title 101
Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis
###end article-title 101
###begin article-title 102
Estimating generalized ordered logit models
###end article-title 102
###begin article-title 103
Body weight status of adults: United States, 1997-98
###end article-title 103
###begin article-title 104
The associations between blood lipids and the Food Guide Pyramid: Findings from the Third National Health and Nutrition Examination Survey
###end article-title 104
###begin article-title 105
###xml 18 23 <span type="species:ncbi:9606">human</span>
Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids
###end article-title 105
###begin article-title 106
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity
###end article-title 106
###begin article-title 107
###xml 110 115 <span type="species:ncbi:9606">human</span>
A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes
###end article-title 107
###begin article-title 108
Lipoprotein lipase mass and activity in severe hypertriglyceridemia
###end article-title 108
###begin article-title 109
Pre-heparin lipoprotein lipase mass
###end article-title 109
###begin article-title 110
###xml 135 140 <span type="species:ncbi:9606">human</span>
Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma
###end article-title 110
###begin article-title 111
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
Development and evaluation of a direct sandwich-enzyme-linked immunosorbent assay for the quantification of human hepatic triglyceride lipase mass in human plasma
###end article-title 111
###begin article-title 112
Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins
###end article-title 112
###begin article-title 113
Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution
###end article-title 113
###begin article-title 114
Fasting and daylong triglycerides in obesity with and without type 2 diabetes
###end article-title 114
###begin article-title 115
Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases
###end article-title 115
###begin article-title 116
Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I
###end article-title 116
###begin article-title 117
High density lipoprotein 2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase
###end article-title 117
###begin article-title 118
###xml 59 64 <span type="species:ncbi:9606">human</span>
Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase
###end article-title 118
###begin article-title 119
In vivo interactions of apolipoprotein A-II, apolipoprotein A-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
###end article-title 119
###begin article-title 120
Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity
###end article-title 120
###begin article-title 121
Apolipoproteins regulate kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high-density lipoproteins
###end article-title 121
###begin article-title 122
Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase
###end article-title 122
###begin article-title 123
Regulated expression of endothelial cell-derived lipase
###end article-title 123
###begin article-title 124
###xml 91 94 <span type="species:ncbi:9606">men</span>
Relationship between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus
###end article-title 124
###begin article-title 125
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity
###end article-title 125
###begin article-title 126
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells
###end article-title 126
###begin article-title 127
###xml 43 49 <span type="species:ncbi:9606">humans</span>
Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism
###end article-title 127
###begin title 128
Abbreviations
###end title 128
###begin p 129
body mass index
###end p 129
###begin p 130
coronary artery calcification
###end p 130
###begin p 131
coronary artery disease
###end p 131
###begin p 132
confidence interval
###end p 132
###begin p 133
endothelial lipase
###end p 133
###begin p 134
high-density lipoprotein cholesterol
###end p 134
###begin p 135
hepatic lipase
###end p 135
###begin p 136
homeostasis model assessment
###end p 136
###begin p 137
interquartile range
###end p 137
###begin p 138
low-density lipoprotein
###end p 138
###begin p 139
lipoprotein lipase
###end p 139
###begin p 140
nuclear magnetic resonance
###end p 140
###begin p 141
Study of the Inherited Risk of Atherosclerosis
###end p 141
###begin p 142
very low-density lipoprotein
###end p 142
###begin title 143
Figures and Tables
###end title 143
###begin title 144
Pre-Heparin EL Mass Concentrations Were Determined in Subgroups According to the Presence of Increasing Numbers of Metabolic Syndrome Factors
###end title 144
###begin p 145
There was an increase in median pre-heparin EL mass as the number of metabolic syndrome factors increased. Median values and IQR are listed above each box.
###end p 145
###begin title 146
###xml 99 102 <span type="species:ncbi:9606">Men</span>
###xml 107 112 <span type="species:ncbi:9606">Women</span>
Coronary Artery Calcification Scores Were Compared across Quartiles of Pre-Heparin EL Mass in Both Men and Women
###end title 146
###begin p 147
The box represents the 25th to 75th percentile, and the line represents the median CAC score within a given pre-heparin EL mass quartile. The whiskers represent the fifth and 95th percentiles. The diamonds are outliers above the 95th percentile. There was an increase in CAC scores as EL mass increased.
###end p 147
###begin title 148
Clinical and Biochemical Characteristics of the Cohort
###end title 148
###begin title 149
Association of EL Mass with Cardiovascular Risk Factor
###end title 149
###begin title 150
Correlations between Post-Heparin EL Mass and Lipoprotein Subclasses Assessed by NMR
###end title 150
###begin title 151
Multivariable Association of Plasma EL Concentrations with Coronary Artery Calcification
###end title 151
###begin p 152
Citation: Badellino KO, Wolfe ML, Reilly MP, Rader DJ (2006) Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 3(2): e22.
###end p 152

